Skip to main content
Abstract 2862: Evolution of clinically relevant variants in advanced pediatric sarcomas.
Abstract 138: UCHL5 and PAX3-FOXO1 resolve replication stress in rhabdomyosarcoma.
Abstract 1759: Integrative longitudinal genomic analysis of therapy-resistant and metastatic pediatric cancers.
Abstract 1509: Longitudinal profiling of high-risk pediatric malignancies using a multiomics approach.
Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages.
N-myc-Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma.
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.
Abstract 54: Integrative analysis of whole-genome and RNA sequencing in high-risk pediatric malignancies.
Abstract CT015: A phase 1 dose escalation study of TB-403 in pediatric relapsed or refractory medulloblastoma, neuroblastoma, Ewing sarcoma, or alveolar rhabdomyosarcoma.
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers.